Vaccines have played a landmark role in medical history, helping to control or eradicate major diseases such as smallpox, measles, flu and polio. This effective form of treatment is also a significant part of our Issels® integrative immunotherapy for cancer programs.
How Do Vaccines Work?
The science behind vaccines may sound counterintuitive. Many vaccines are made from a weakened form of the microorganism that it’s being developed to fight. Once introduced into your system, the vaccines “teach” your immune system to recognize the microorganism as a threat to be attacked and destroyed.
The Issels® Vaccine Program
Our personalized cancer vaccines and cell therapy protocols are created from the patient’s own immune cells and combined with the immunobologic core treatment to target the tumor and its specific microenvironment to optimize their results.
We offer specialized cancer vaccines at the Issels® immuno-oncology center, including Autologous Dendritic Cells Cancer Vaccine, Prostate Cancer Vaccine, as well as the Issels Autologous Vaccine and combine them with the Lymphokine-Activated Killer (LAK) Cell and Natural Killer (NK) Cell protocols.
These vaccines and cell therapies are autologous, meaning they are created from the patient’s own blood. Since the blood cells provide information about the patient’s internal environment, the vaccines can be tailored to target the patient’s unique cancer-fighting properties.
Immunotherapy for Cancer: Boosting Your Body’s Natural Defenses
Cancer vaccines are only one of the non-toxic protocols we use to activate your body’s own immune response against tumors. Contact us today to learn why Issels® has been a leader in immunotherapy for cancer treatments for more than 50 years.
As part of the American Cancer Society’s initiative to eliminate cancer, they have funded research by some of the most brilliant minds in the medical field. Among the 46 ACS-funded scientists who have gone on to win the Nobel Prize is a doctor who did groundbreaking work involving dendritic cell therapy.
Top Scientists Go to Bat for ACS
Immunotherapy for cancer received a major boost when Dr. Ralph M. Steinman of Rockefeller University discovered the dendritic cell, which plays a vital role in the function of the immune system. Dendritic cells trigger responses in T cells, allowing them to more effectively target invading cancer cells.
Dr. Bruce A. Beutler, professor of genetics and immunology at Scripps Research Institute in San Diego, is another Nobel laureate who received a grant from ACS. Along with his colleague Jules Hoffman, head of a laboratory in Strasburg, France, Dr. Beutler conducted extensive research concerning innate immunity, which is the body’s first line of defense against cancer cells and other invaders.
ACS Grants Lead to Improved Cancer Treatments
Dr. Stein’s work led to the development of Provenge, a prostate cancer vaccine that has become a valuable part of immunotherapy for cancer. The findings of Dr. Beutler could ultimately result in more effective treatments for cancer as well as rheumatoid arthritis and other chronic inflammatory diseases.
Issels® Offers State-of-the-Art Immunotherapy for Cancer
Cancer vaccines are just one of the advanced non-toxic therapies used at our Issels® center. Contact us to learn more about how our personalized immunotherapy protocols have helped patients with all forms of cancer, including leukemia, melanoma and breast cancer.